Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 10 | Longs Won 7/10 70% | Profit Factor 1.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $12,687.97 |
| Average Win $9,042.95 | Best Trade (Sep 02) $16,137.72 | Sharpe Ratio -30.11 |
| Average Loss -$14,734.11 | Worst Trade (Mar 21) -$22,312.15 | Z-Score 1.06 (71.26%) |
| Commissions $0 | Avg. Trade Length 1m 2w 4d | Expectancy $1,909.83 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 0.21% | 1.36% | 4.01% | 8.64% | 15.69% | 25.53% | 38.55% | 55.08% | 75.46% |
| Consecutive Losing Trades | 8 | 7 | 6 | 6 | 5 | 4 | 3 | 2 | 2 | 1 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
VCYT Veracyte Inc. | 2,700.64 | $108,403.76 | $119,098.3 | - | $10,694.54 | 9.87% | -0.653% |